Telix Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Cochlear AUD 383.1M 130.5M 2024-12
CSL 1.52B 133M 2024-12
Integral Diagnostics 17.99M 15.86M 2023-12
Mayne Pharma 110.07M 838K 2024-06
Medical Developments International AUD 17.62M 7.88M 2024-12
Mesoblast 62.56M 14.58M 2024-06
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Pacific Edge NZD 22.57M 637K 2025-03
Paradigm Biopharmaceuticals 17.82M 15.73M 2024-06
Polynovo 45.91M 330K 2024-06
PYC Therapeutics AUD 49.25M 17.62M 2024-12
Ramsay Health Care AUD 341.1M 321.2M 2024-12
ResMed USD 521.94M 95.58M 2024-12
Sonic Healthcare 645M 25.39M 2024-06


Telix Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.